Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Interest Expense : ¥-18 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Guangzhou Kingmed Diagnostics Group Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Guangzhou Kingmed Diagnostics Group Co's interest expense for the three months ended in Mar. 2025 was ¥ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Guangzhou Kingmed Diagnostics Group Co's Operating Income for the three months ended in Mar. 2025 was ¥ 65 Mil. Guangzhou Kingmed Diagnostics Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -4 Mil. Guangzhou Kingmed Diagnostics Group Co's Interest Coverage for the quarter that ended in Mar. 2025 was 15.64. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Guangzhou Kingmed Diagnostics Group Co Interest Expense Historical Data

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangzhou Kingmed Diagnostics Group Co Interest Expense Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-29.26

-27.55

-23.65

-20.39

-18.43

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-4.91	-4.42	-4.83	-4.27	-4.15

Guangzhou Kingmed Diagnostics Group Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-18 Mil.

Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Guangzhou Kingmed Diagnostics Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥-4 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥65 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥644 Mil.

Guangzhou Kingmed Diagnostics Group Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	64.955	/	-4.154
	=	15.64

The higher the ratio, the stronger the company's financial strength is.

Guangzhou Kingmed Diagnostics Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangzhou Kingmed Diagnostics Group Co Ltd (SHSE:603882) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000

Website

http://www.kingmed.com.cn

Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2023, KingMed has 49 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.

Executives

Hao Bi Xi	Directors, senior managers
Wang Ling Lai	Director
Yu Shi Hui	senior management
Liang Yao Ming	Director
Peng Yong Xiang	Director

Guangzhou Kingmed Diagnostics Group Co Headlines

No Headlines